After resolving FCPA violations in 2016, GSK reports new problem to US
The pharmaceutical company has alerted US authorities to an inquiry into third-party advisers that it engaged during the course of a bribery investigation in China.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10